Advertisement
Advertisement
CORT
Corcept Therapeutics Inc.
110.29
USDSponsored
-4.57
-3.98%
Sep 18, 15:59 UTC -4
Closed
After-Market
111.28
+0.99
+0.89%
CORT Earnings Reports
Positive Surprise Ratio
CORT beat 27 of 43 last estimates.
63%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$343.10M
/$0.83
Implied change from Q2 26 (Revenue/ EPS)
+33.95%
/+130.56%
Implied change from Q3 25 (Revenue/ EPS)
+65.24%
/+418.75%
Corcept Therapeutics Inc. earnings per share and revenue
On Jul 29, 2026, CORT reported earnings of 0.36 USD per share (EPS) for Q2 26, beating the estimate of 0.00 USD, resulting in a 6958.82% surprise. Revenue reached 256.15 million, compared to an expected 226.26 million, with a 13.21% difference. The market reacted with a +27.29% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of 0.83 USD, with revenue projected to reach 343.10 million USD, implying an increase of 130.56% EPS, and increase of 33.95% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Apnimed, Inc. Common Stock
Report Date
Sep 08, 2026 For Q2 26
Estimate
-$0.52
Actual
-$0.34
Surprise
+34.64%
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-Actual
-$0.54
Surprise
-
FAQ
What were Corcept Therapeutics Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Corcept Therapeutics Inc. reported EPS of $0.36, beating estimates by 6958.82%, and revenue of $256.15M, 13.21% above expectations.
How did the market react to Corcept Therapeutics Inc.'s Q2 2026 earnings?
The stock price moved up 27.29%, changed from $92.95 before the earnings release to $118.32 the day after.
When is Corcept Therapeutics Inc. expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Corcept Therapeutics Inc.'s next earnings report?
Based on 7
analysts, Corcept Therapeutics Inc. is expected to report EPS of $0.83 and revenue of $343.10M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.